BioSpace News Archive

Append Medical Completes $7.4M Million Series A Round

Append Medical, developer of the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage exclusion, announced the completion of a $7.4 million Series A financing round.

August 4, 2021
·
2 min read
Business

Gamida Cell Announces the Date of Its Second Quarter 2021 Financial Results and Webcast

Gamida Cell Ltd. today announced that the company will host a conference call and live audio webcast on Wednesday, August 11, 2021, at 8:00 a.m. ET to review its second quarter 2021 financial results and provide an update on the company.

August 4, 2021
·
3 min read
Genetown

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will be presenting during a fireside chat at the upcoming virtual Wedbush PacGrow Healthcare Conference on Tuesday, August 10 th , 2021 at 8:35am ET.

August 4, 2021
·
1 min read
Biotech Bay

Cortexyme to Present at Canaccord Genuity’ s 41st Annual Growth Conference on August 11th

Cortexyme to Present at Canaccord Genuity’ s 41 st Annual Growth Conference on August 11 th

August 4, 2021
·
1 min read
FDA

Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of retinitis pigmentosa (RP).

August 4, 2021
·
7 min read
Business

UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

August 4, 2021
·
16 min read
Business

Clovis Oncology Announces Second Quarter 2021 Operating Results

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended June 30, 2021, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook for the rest of the year.

August 4, 2021
·
18 min read
Business

ImmunoPrecise Welcomes Vice President of Client Relations and Vice President of Marketing to its Leadership Team, Accelerating Its Growth and Expansion Plans

IMMUNOPRECISE ANTIBODIES LTD. today announces the promotion of Dr. Barry Duplantis, Ph.D., to VP of Client Relations and welcomes Ms. Carla Dahl as VP of Marketing.

August 4, 2021
·
4 min read
Deals

Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products

Zoetis Inc. (NYSE: ZTS) today announced it has entered into an agreement to acquire Jurox, a privately held animal health company, which develops, manufactures and markets a wide range of veterinary medicines for treating companion animals and livestock.

August 4, 2021
·
5 min read
Biotech Bay

Ultragenyx to Participate in Gene Therapy Panel at Wedbush PacGrow Healthcare Conference

Ultragenyx Pharmaceutical Inc. today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President will participate in a panel titled Miss Con-GENE-iality - Updates in Gene Tx on Wednesday, August 11, 2021

August 4, 2021
·
1 min read